Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Index by author

November 1, 2018; Volume 59,Issue 11
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Borges-neto, Salvador

    1. You have access
      Predictors of Survival in 211 Patients with Stage IV Pulmonary and Gastroenteropancreatic MIBG-Positive Neuroendocrine Tumors Treated with 131I-MIBG
      Ari Kane, Matthew P. Thorpe, Michael A. Morse, Brandon A. Howard, Jorge D. Oldan, Jason Zhu, Terence Z. Wong, Neil A. Petry, Robert Reiman and Salvador Borges-Neto
      Journal of Nuclear Medicine November 1, 2018, 59 (11) 1708-1713; DOI: https://doi.org/10.2967/jnumed.117.202150
  2. Bushnell, David L.

    1. You have access
      90Y-DOTATOC Dosimetry–Based Personalized Peptide Receptor Radionuclide Therapy
      Yusuf Menda, Mark T. Madsen, Thomas M. O’Dorisio, John J. Sunderland, G. Leonard Watkins, Joseph S. Dillon, Sarah L. Mott, Michael K. Schultz, Gideon K.D. Zamba, David L. Bushnell and M. Sue O’Dorisio
      Journal of Nuclear Medicine November 1, 2018, 59 (11) 1692-1698; DOI: https://doi.org/10.2967/jnumed.117.202903
  3. Calais, Jeremie

    1. You have access
      Potential Impact of 68Ga-PSMA-11 PET/CT on the Planning of Definitive Radiation Therapy for Prostate Cancer
      Jeremie Calais, Amar U. Kishan, Minsong Cao, Wolfgang P. Fendler, Matthias Eiber, Ken Herrmann, Francesco Ceci, Robert E. Reiter, Matthew B. Rettig, John V. Hegde, Narek Shaverdian, Chris R. King, Michael L. Steinberg, Johannes Czernin and Nicholas G. Nickols
      Journal of Nuclear Medicine November 1, 2018, 59 (11) 1714-1721; DOI: https://doi.org/10.2967/jnumed.118.209387
  4. Cao, Minsong

    1. You have access
      Potential Impact of 68Ga-PSMA-11 PET/CT on the Planning of Definitive Radiation Therapy for Prostate Cancer
      Jeremie Calais, Amar U. Kishan, Minsong Cao, Wolfgang P. Fendler, Matthias Eiber, Ken Herrmann, Francesco Ceci, Robert E. Reiter, Matthew B. Rettig, John V. Hegde, Narek Shaverdian, Chris R. King, Michael L. Steinberg, Johannes Czernin and Nicholas G. Nickols
      Journal of Nuclear Medicine November 1, 2018, 59 (11) 1714-1721; DOI: https://doi.org/10.2967/jnumed.118.209387
  5. Ceci, Francesco

    1. You have access
      Potential Impact of 68Ga-PSMA-11 PET/CT on the Planning of Definitive Radiation Therapy for Prostate Cancer
      Jeremie Calais, Amar U. Kishan, Minsong Cao, Wolfgang P. Fendler, Matthias Eiber, Ken Herrmann, Francesco Ceci, Robert E. Reiter, Matthew B. Rettig, John V. Hegde, Narek Shaverdian, Chris R. King, Michael L. Steinberg, Johannes Czernin and Nicholas G. Nickols
      Journal of Nuclear Medicine November 1, 2018, 59 (11) 1714-1721; DOI: https://doi.org/10.2967/jnumed.118.209387
  6. Chaple, Ivis F.

    1. You have access
      Production and Use of the First-Row Transition Metal PET Radionuclides 43,44Sc, 52Mn, and 45Ti
      Ivis F. Chaple and Suzanne E. Lapi
      Journal of Nuclear Medicine November 1, 2018, 59 (11) 1655-1659; DOI: https://doi.org/10.2967/jnumed.118.213264
  7. Chen, Christopher

    1. You have access
      Development of a Dedicated Rebinner with Rigid Motion Correction for the mMR PET/MR Scanner, and Validation in a Large Cohort of 11C-PIB Scans
      Anthonin Reilhac, Inés Merida, Zacharie Irace, Mary C. Stephenson, Ashley A. Weekes, Christopher Chen, John J. Totman, David W. Townsend, Hadi Fayad and Nicolas Costes
      Journal of Nuclear Medicine November 1, 2018, 59 (11) 1761-1767; DOI: https://doi.org/10.2967/jnumed.117.206375
  8. Chen, Xiaoyuan

    1. You have access
      Safety, Pharmacokinetics, and Dosimetry of a Long-Acting Radiolabeled Somatostatin Analog 177Lu-DOTA-EB-TATE in Patients with Advanced Metastatic Neuroendocrine Tumors
      Jingjing Zhang, Hao Wang, Orit Jacobson, Yuejuan Cheng, Gang Niu, Fang Li, Chunmei Bai, Zhaohui Zhu and Xiaoyuan Chen
      Journal of Nuclear Medicine November 1, 2018, 59 (11) 1699-1705; DOI: https://doi.org/10.2967/jnumed.118.209841
  9. Cheng, Yuejuan

    1. You have access
      Safety, Pharmacokinetics, and Dosimetry of a Long-Acting Radiolabeled Somatostatin Analog 177Lu-DOTA-EB-TATE in Patients with Advanced Metastatic Neuroendocrine Tumors
      Jingjing Zhang, Hao Wang, Orit Jacobson, Yuejuan Cheng, Gang Niu, Fang Li, Chunmei Bai, Zhaohui Zhu and Xiaoyuan Chen
      Journal of Nuclear Medicine November 1, 2018, 59 (11) 1699-1705; DOI: https://doi.org/10.2967/jnumed.118.209841
  10. Choyke, Peter L.

    1. You have access
      A Prospective Comparison of 18F-Sodium Fluoride PET/CT and PSMA-Targeted 18F-DCFBC PET/CT in Metastatic Prostate Cancer
      Stephanie A. Harmon, Ethan Bergvall, Esther Mena, Joanna H. Shih, Stephen Adler, Yolanda McKinney, Sherif Mehralivand, Deborah E. Citrin, Anna Couvillon, Ravi A. Madan, James L. Gulley, Ronnie C. Mease, Paula M. Jacobs, Martin G. Pomper, Baris Turkbey, Peter L. Choyke and M. Liza Lindenberg
      Journal of Nuclear Medicine November 1, 2018, 59 (11) 1665-1671; DOI: https://doi.org/10.2967/jnumed.117.207373
« Previous (Pages : 1 2 3 4 5 6 7 ... 18) Next »
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 59 (11)
Journal of Nuclear Medicine
Vol. 59, Issue 11
November 1, 2018
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Issue highlights

  • Development of a SPECT Tracer to Image c-Met Expression in a Xenograft Model of Non–Small Cell Lung Cancer
  • Potential Impact of 68Ga-PSMA-11 PET/CT on the Planning of Definitive Radiation Therapy for Prostate Cancer
  • The Network Degeneration Hypothesis: Spread of Neurodegenerative Patterns Along Neuronal Brain Networks
  • Treatment of Primary Liver Tumors and Liver Metastases, Part 1: Nuclear Medicine Techniques
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire